BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND FGFR1, CEK, 2260, ENSG00000077782, P11362, FLT2, CD331, H3, HBGFR, FGFBR, H5, KAL2, H2, BFGFR, N-SAM, H4
755 results:

  • 1. Select EZH2 inhibitors enhance viral mimicry effects of DNMT inhibition through a mechanism involving NFAT:AP-1 signaling.
    Chomiak AA; Tiedemann RL; Liu Y; Kong X; Cui Y; Wiseman AK; Thurlow KE; Cornett EM; Topper MJ; Baylin SB; Rothbart SB
    Sci Adv; 2024 Mar; 10(13):eadk4423. PubMed ID: 38536911
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Use of tryptic peptide MALDI mass spectrometry imaging to identify the spatial proteomic landscape of colorectal cancer liver metastases.
    Li CMY; Briggs MT; Lee YR; Tin T; Young C; Pierides J; Kaur G; Drew P; Maddern GJ; Hoffmann P; Klingler-Hoffmann M; Fenix K
    Clin Exp Med; 2024 Mar; 24(1):53. PubMed ID: 38492056
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Synergic actions of botulinum neurotoxin A and oxaliplatin on colorectal tumour cell death through the upregulation of TRPM2 channel-mediated oxidative stress.
    Demir S; Duman İ; Nazıroğlu M
    Clin Exp Pharmacol Physiol; 2024 Apr; 51(4):e13844. PubMed ID: 38350599
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Cost-effectiveness of pembrolizumab for previously treated MSI-H/dMMR solid tumours in the UK.
    McCarthy G; Young K; Madin-Warburton M; Mantaian T; Brook E; Metcalfe K; Mikelson J; Xu R; Seyla-Hammer C; Aguiar-Ibáñez R; Amonkar M
    J Med Econ; 2024; 27(1):279-291. PubMed ID: 38293714
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Biomarkers of peripheral blood neutrophil extracellular traps in the diagnosis and progression of malignant tumors.
    Wang M; Lv X; Wang Y; Li Y; Li H; Shen Z; Zhao L
    Cancer Med; 2024 Feb; 13(3):e6935. PubMed ID: 38230764
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Cationic micelle delivery of a multi-epitope vaccine candidate derived from tumor-associated antigens, causing regression in established CT26 colorectal tumors in mice.
    Sabzehei F; Taromchi AH; Ramazani A; Nedaei K; Feizi A; Arsang-Jang S; Danafar H
    J Biomed Mater Res A; 2024 May; 112(5):733-742. PubMed ID: 38088136
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Soluble B7-H3 in colorectal cancer.
    Kovaleva OV; Gratchev AN; Sokolov NY; Maslennikov VV; Kuzmin YB; Gershtein ES; Alferov AA; Mamedli ZZ; Stilidi IS; Kushlinskii NE
    Bull Exp Biol Med; 2023 Nov; 176(1):87-90. PubMed ID: 38085395
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. B7-H3 regulates anti-tumor immunity and promotes tumor development in colorectal cancer.
    Zhang H; Zhu M; Zhao A; Shi T; Xi Q
    Biochim Biophys Acta Rev Cancer; 2024 Jan; 1879(1):189031. PubMed ID: 38036107
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Insight into the design of FGFR4 selective inhibitors in cancer therapy: Prospects and challenges.
    Chen X; Huang Y; Chen B; Liu H; Cai Y; Yang Y
    Eur J Med Chem; 2024 Jan; 263():115947. PubMed ID: 37976704
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. NF-κB downstream miR-1262 disturbs colon cancer cell malignant behaviors by targeting fgfr1.
    Zhang W; Huang Z; Xiao Z; Wang H; Liao Q; Deng Z; Wu D; Wang J; Li Y
    Acta Biochim Biophys Sin (Shanghai); 2023 Nov; 55(11):1819-1832. PubMed ID: 37867436
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Mild-Photothermal Effect Induced High Efficiency Ferroptosis-Boosted-Cuproptosis Based on Cu
    Chen W; Xie W; Gao Z; Lin C; Tan M; Zhang Y; Hou Z
    Adv Sci (Weinh); 2023 Nov; 10(33):e2303694. PubMed ID: 37822154
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Genome-Wide Association and Two-Sample Mendelian Randomization Analyses of Plasma Ghrelin and Gastrointestinal cancer Risk.
    Larsson SC; Höijer J; Sun J; Li X; Burgess S; Michaëlsson K
    Cancer Epidemiol Biomarkers Prev; 2023 Dec; 32(12):1771-1776. PubMed ID: 37791980
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. LINC00922 decoys SIRT3 to facilitate the metastasis of colorectal cancer through up-regulation the H3K27 crotonylation of ETS1 promoter.
    Liao M; Sun X; Zheng W; Wu M; Wang Y; Yao J; Ma Y; Gao S; Pei D
    Mol Cancer; 2023 Oct; 22(1):163. PubMed ID: 37789393
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Engineered Microbial Nanohybrids for Tumor-Mediated NIR II Photothermal Enhanced Ferroptosis/Cuproptosis and Immunotherapy.
    Ruan Y; Zhuang H; Zeng X; Lin L; Wang X; Xue P; Xu S; Chen Q; Yan S; Huang W
    Adv Healthc Mater; 2024 Feb; 13(4):e2302537. PubMed ID: 37742322
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. CXXC finger protein 1 (CFP1) bridges the reshaping of genomic H3K4me3 signature to the advancement of lung adenocarcinoma.
    Fan T; Xiao C; Liu H; Liu Y; Wang L; Tian H; Li C; He J
    Signal Transduct Target Ther; 2023 Sep; 8(1):369. PubMed ID: 37735441
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. The Potential Dual Role of H2.0-like Homeobox in the Tumorgenesis and Development of colorectal cancer and Its Prognostic Value.
    Chen S; Zhang L; Wang K; Huo J; Zhang S; Zhang X
    Can J Gastroenterol Hepatol; 2023; 2023():5521544. PubMed ID: 37719132
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. A new class of anticancer activity with computational studies for a novel bioactive aminophosphonates based on pyrazole moiety.
    Baren MH; Ibrahim SA; Al-Rooqi MM; Ahmed SA; El-Gamil MM; Hekal HA
    Sci Rep; 2023 Sep; 13(1):14680. PubMed ID: 37673913
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Anticancer Study of a Novel Pan-HDAC Inhibitor MPT0G236 in colorectal cancer Cells.
    Tsai FL; Huang HL; Lai MJ; Liou JP; Pan SL; Yang CR
    Int J Mol Sci; 2023 Aug; 24(16):. PubMed ID: 37628767
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Tumor-derived lactate promotes resistance to bevacizumab treatment by facilitating autophagy enhancer protein RUBCNL expression through histone H3 lysine 18 lactylation (H3K18la) in colorectal cancer.
    Li W; Zhou C; Yu L; Hou Z; Liu H; Kong L; Xu Y; He J; Lan J; Ou Q; Fang Y; Lu Z; Wu X; Pan Z; Peng J; Lin J
    Autophagy; 2024 Jan; 20(1):114-130. PubMed ID: 37615625
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Molecular insights into recognition of GUCY2C by T-cell engaging bispecific antibody anti-GUCY2CxCD3.
    Rampuria P; Mosyak L; Root AR; Svenson K; Agostino MJ; LaVallie ER
    Sci Rep; 2023 Aug; 13(1):13408. PubMed ID: 37591971
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 38.